期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
A natural nano-platform:Advances in drug delivery system with recombinant high-density lipoprotein
1
作者 Zhilong Xie Guohui Zhang +6 位作者 Ya Meng Yefei Tong Jian Deng Honghui Li Qingqing Ma shisong han Wenjun Ni 《Chinese Chemical Letters》 SCIE CAS 2024年第11期74-86,共13页
Developing natural nano-platforms with high biocompatibility and natural targeting ability represents great significance for drug delivery.High-density lipoprotein(HDL),a natural lipid-protein complex,plays important ... Developing natural nano-platforms with high biocompatibility and natural targeting ability represents great significance for drug delivery.High-density lipoprotein(HDL),a natural lipid-protein complex,plays important roles in physiological activities,particularly in reverse cholesterol transport(RCT)and be closely associated with atherosclerotic cardiovascular diseases.Recent studies have demonstrated that HDLs have the potential to serve as ideal drug carriers.Recombinant HDLs(r HDLs)have been used to encapsulate substances such as small interfering RNA(siRNA),drugs,and contrast agents,fully utilizing the biocompatibility and targeting ability of r HDL in the body and providing new strategies for drug delivery and disease treatment.In this review,we discussed in detail the basic principles of HDL as a drug delivery system,the mechanisms of targeted drug delivery,and several methods for preparing HDL nanoparticles.Afterward,we comprehensively reviewed the applications of HDL as a drug carrier in cardiovascular diseases,cancer treatment(such as glioblastoma,breast cancer,hepatocellular carcinoma and urologic cancers)and some other fields.Finally,we reviewed the therapeutic effects and safety of HDL nanoparticles in clinical studies.Through a review and summary of these research advances,we aim to fully understand the potential of HDL as a drug carrier in clinical applications,providing valuable references and guidance for future research and expedites the translational application of HDL as drug carriers. 展开更多
关键词 High-density lipoproteins Drug delivery Apolipoprotein Targeting mechanisms HDL nanoparticle preparation Cardiovascular disease Cancer treatment
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部